SABS Competitors & Alternatives
Compare SAB Biotherapeutics Inc with similar stocks in the same industry
Biotechnology
SABS
Main Stock$3.08
Tradestie Score
39
Market Cap
$20.61M
Revenue Growth
-0.6%
Analyst Upside
+277.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.81
|
$307.12M | - | 36 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.39
|
$304.12M | - | 51 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.87
|
$297.23M | - | 30 | Compare |
|
OMER
Omeros Corporation
|
$17.99
|
$281.75M | 14.9 | 52 | Compare |
|
DBVT
DBV Technologies S.A.
|
$11.43
|
$275.54M | - | 22 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.32
|
$269.08M | 0.1 | 47 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$23.90
|
$256.54M | - | 30 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.80
|
$240.89M | - | 42 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.95
|
$231.77M | - | 42 | Compare |
More SABS Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry